Literature DB >> 20627413

Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): somatosensory abnormalities in 1236 patients with different neuropathic pain syndromes.

C Maier1, R Baron, T R Tölle, A Binder, N Birbaumer, F Birklein, J Gierthmühlen, H Flor, C Geber, V Huge, E K Krumova, G B Landwehrmeyer, W Magerl, C Maihöfner, H Richter, R Rolke, A Scherens, A Schwarz, C Sommer, V Tronnier, N Üçeyler, M Valet, G Wasner, D-R Treede.   

Abstract

Neuropathic pain is accompanied by both positive and negative sensory signs. To explore the spectrum of sensory abnormalities, 1236 patients with a clinical diagnosis of neuropathic pain were assessed by quantitative sensory testing (QST) following the protocol of DFNS (German Research Network on Neuropathic Pain), using both thermal and mechanical nociceptive as well as non-nociceptive stimuli. Data distributions showed a systematic shift to hyperalgesia for nociceptive, and to hypoesthesia for non-nociceptive parameters. Across all parameters, 92% of the patients presented at least one abnormality. Thermosensory or mechanical hypoesthesia (up to 41%) was more frequent than hypoalgesia (up to 18% for mechanical stimuli). Mechanical hyperalgesias occurred more often (blunt pressure: 36%, pinprick: 29%) than thermal hyperalgesias (cold: 19%, heat: 24%), dynamic mechanical allodynia (20%), paradoxical heat sensations (18%) or enhanced wind-up (13%). Hyperesthesia was less than 5%. Every single sensory abnormality occurred in each neurological syndrome, but with different frequencies: thermal and mechanical hyperalgesias were most frequent in complex regional pain syndrome and peripheral nerve injury, allodynia in postherpetic neuralgia. In postherpetic neuralgia and in central pain, subgroups showed either mechanical hyperalgesia or mechanical hypoalgesia. The most frequent combinations of gain and loss were mixed thermal/mechanical loss without hyperalgesia (central pain and polyneuropathy), mixed loss with mechanical hyperalgesia in peripheral neuropathies, mechanical hyperalgesia without any loss in trigeminal neuralgia. Thus, somatosensory profiles with different combinations of loss and gain are shared across the major neuropathic pain syndromes. The characterization of underlying mechanisms will be needed to make a mechanism-based classification feasible. Copyright (c) 2010 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20627413     DOI: 10.1016/j.pain.2010.05.002

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  233 in total

1.  Pain processing by spinal microcircuits: afferent combinatorics.

Authors:  Steven A Prescott; Stéphanie Ratté
Journal:  Curr Opin Neurobiol       Date:  2012-03-10       Impact factor: 6.627

2.  [Physicians do not treat averages--but therapy responders!].

Authors:  C Maier; R Baron
Journal:  Schmerz       Date:  2012-02       Impact factor: 1.107

Review 3.  Combination pharmacotherapy for the treatment of neuropathic pain in adults.

Authors:  Luis Enrique Chaparro; Philip J Wiffen; R Andrew Moore; Ian Gilron
Journal:  Cochrane Database Syst Rev       Date:  2012-07-11

4.  [Diagnostic comparison of thermal parameters of quantitative sensory testing and laser stimulation in postherpetic neuralgia].

Authors:  M Franz; A Ritter; C Puta; W H R Miltner; T Weiss
Journal:  Schmerz       Date:  2016-02       Impact factor: 1.107

5.  Approaches to measure paediatric chemotherapy-induced peripheral neurotoxicity: a systematic review.

Authors:  Ellen M Lavoie Smith; Clare Kuisell; Grace A Kanzawa-Lee; Celia M Bridges; Paola Alberti; Guido Cavaletti; Rima Saad; Susanna Park
Journal:  Lancet Haematol       Date:  2020-05       Impact factor: 18.959

Review 6.  Improving the translation of analgesic drugs to the clinic: animal models of neuropathic pain.

Authors:  N Percie du Sert; A S C Rice
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

Review 7.  [Neuropathic pain: pathophysiology, assessment, and therapy].

Authors:  C Sommer
Journal:  Schmerz       Date:  2013-12       Impact factor: 1.107

Review 8.  The Pharmacological Therapy of Chronic Neuropathic Pain.

Authors:  Andreas Binder; Ralf Baron
Journal:  Dtsch Arztebl Int       Date:  2016-09-16       Impact factor: 5.594

Review 9.  Preclinical Pain Research: Can We Do Better?

Authors:  J David Clark
Journal:  Anesthesiology       Date:  2016-11       Impact factor: 7.892

10.  Decreased spinothalamic and dorsal column medial lemniscus-mediated function is associated with neuropathic pain after spinal cord injury.

Authors:  Yenisel Cruz-Almeida; Elizabeth R Felix; Alberto Martinez-Arizala; Eva G Widerström-Noga
Journal:  J Neurotrauma       Date:  2012-08-27       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.